Literature DB >> 17884039

Memory and learning impairment induced by dexamethasone in senescent but not young mice.

Yu-You Yao1, Dong-Mei Liu, Dong-Fang Xu, Wei-Ping Li.   

Abstract

In this study, the memory and learning impairment induced by dexamethasone in young mice and senescent mice were evaluated by step-down inhibitory avoidance task and passive avoidance test. Colorimetric MTT(tetrazole 3-(4,5-dimethylthiazol-2-yl-)-2,5-diphenyltetrazolium bromide) assay and TUNEL staining were used to investigate the influence of dexamethasone on hippocampal neuronal cell death with amyloid beta-protein. It was determined the effect of dexamethasone on intracellular calcium ([Ca(2+)](i)) with amyloid beta-protein 25-35 by fluorescence imaging with a confocal laser microscope using fluo-3 acetoxymethylester (AM) as a fluorescent dye. The effect of dexamethasone on amyloid beta-protein 25-35-induced nuclear factor kappaB (NF-kappaB) was analyzed by western blot. The results showed that twenty one days dexamethasone exposure resulted in an impairment of memory and learning in senescent but not young mice. Pretreatment of isolated hippocampal neurons with dexamethasone increased the vulnerability of the hippocampal neurons to amyloid beta-protein 25-35, enhanced [Ca(2+)](i) and down-regulated the increased level of nuclear NF-kappaB p65 proteins induced by amyloid beta-protein 25-35. These results demonstrated that glucocorticoids could potentiate the neurotoxic action of amyloid beta-protein by further increasing the level of [Ca(2+)](i) and down-regulating the level of nuclear NF-kappaB protein. Since amyloid beta-protein increases in the brain with aging, glucocorticoids potentiation of the neurotoxic action of amyloid beta-protein maybe one of the mechanisms responsible for glucocorticoids-induced memory and learning impairment in senescent but not young mice, which maybe relevance to the etiology of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17884039     DOI: 10.1016/j.ejphar.2007.07.021

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Short-Term and Long-Term Effects of Dexamethasone on Cognitive Dysfunction Induced by Sevoflurane in Adult Rats.

Authors:  Tuğba Karaman; Serkan Karaman; Serkan Doğru; Hakan Tapar; Aynur Şahin; Mustafa Süren
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-02-01

Review 2.  Adverse stress, hippocampal networks, and Alzheimer's disease.

Authors:  Sarah M Rothman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2009-11-27       Impact factor: 3.843

3.  Schizandrin prevents dexamethasone-induced cognitive deficits.

Authors:  Xiao Xu; Xing Zhou; Xiao-Wen Zhou; Zheng Zhang; Min-Jing Liao; Qi Gao; Huan-Min Luo
Journal:  Neurosci Bull       Date:  2012-07-18       Impact factor: 5.203

Review 4.  A lifespan view of anxiety disorders.

Authors:  Eric J Lenze; Julie Loebach Wetherell
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

Review 5.  Neuropathology of stress.

Authors:  Paul J Lucassen; Jens Pruessner; Nuno Sousa; Osborne F X Almeida; Anne Marie Van Dam; Grazyna Rajkowska; Dick F Swaab; Boldizsár Czéh
Journal:  Acta Neuropathol       Date:  2013-12-08       Impact factor: 17.088

6.  Cistanches alleviates sevoflurane-induced cognitive dysfunction by regulating PPAR-γ-dependent antioxidant and anti-inflammatory in rats.

Authors:  Sheng Peng; Pengyi Li; Peirong Liu; Hongzhu Yan; Juan Wang; Weihua Lu; Chunliang Liu; Yixin Zhou
Journal:  J Cell Mol Med       Date:  2019-12-04       Impact factor: 5.310

7.  Chronic clomipramine treatment reverses depressogenic-like effects of a chronic treatment with dexamethasone in rats.

Authors:  Abderrahim Laaziz; Hicham El Mostafi; Aboubaker Elhessni; Tarik Touil; Hanane Doumar; Abdelhalem Mesfioui
Journal:  IBRO Neurosci Rep       Date:  2022-08-01

8.  Inflammatory process in Alzheimer's Disease.

Authors:  Marco A Meraz-Ríos; Danira Toral-Rios; Diana Franco-Bocanegra; Juana Villeda-Hernández; Victoria Campos-Peña
Journal:  Front Integr Neurosci       Date:  2013-08-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.